2011
DOI: 10.3171/2011.1.focus10317
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas

Abstract: Object The purpose of this study was to analyze preoperative predictors of endocrinological remission following endonasal endoscopic resection of therapy-resistant prolactin-, growth hormone (GH)–, and adrenocorticotropic hormone (ACTH)–secreting pituitary adenomas and to establish benchmarks for cure by using the most recent consensus criteria. Methods The authors reviewed a prospective database of 86 c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
82
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 115 publications
(88 citation statements)
references
References 44 publications
(66 reference statements)
5
82
0
1
Order By: Relevance
“…Series confirming that the operations were carried out by one or two surgeons in a single center or by surgeons each performing 80 pituitary operations per year mostly show higher remission rates (82 -100%) (13,14,15,16,18,20,30,31,32) pointing out the importance of surgical expertise. Other factors affecting biochemical remission are not clearly defined specifically for the microprolactinomas as the reported results include analyses for both micro-and macroprolactinomas.…”
Section: Transsphenoidal Surgery For Microprolactinomasmentioning
confidence: 89%
See 2 more Smart Citations
“…Series confirming that the operations were carried out by one or two surgeons in a single center or by surgeons each performing 80 pituitary operations per year mostly show higher remission rates (82 -100%) (13,14,15,16,18,20,30,31,32) pointing out the importance of surgical expertise. Other factors affecting biochemical remission are not clearly defined specifically for the microprolactinomas as the reported results include analyses for both micro-and macroprolactinomas.…”
Section: Transsphenoidal Surgery For Microprolactinomasmentioning
confidence: 89%
“…Series reporting the outcomes of endoscopic transsphenoidal surgery in microprolactinomas are rather limited ( Table 2). The postoperative remission rates range between 81 and 100%, and in all but one of the studies, there is no available information on previous DA administration (19,28,29,30,31,32,33,34,35). Given that the main advantages of the endoscopic approach involve invasive adenomas, it would be anticipated that the remission rates should not differ between microscopic and endoscopic techniques in microprolactinomas.…”
Section: Transsphenoidal Surgery For Microprolactinomasmentioning
confidence: 99%
See 1 more Smart Citation
“…Detailed descriptions of the surgical technique are provided in our previous articles. 7,9,11,12,30 For statistical power, we divided the approaches into 4 subtypes: 1) transsellar; 2) transplanum; 3) transcribriform, transpterygoid, or transethmoidal; and 4) transcavernous and transclival.…”
Section: Operative Technique and Closure Methodsmentioning
confidence: 99%
“…Using a fully endoscopic approach for patients with acromegaly, Jane et al [ 65 ] achieved a remission rate of 100% for GH-secreting microadenomas and 61% for macroadenomas. Hofstetter et al [ 59 ] analyzed remission rates for all types of functional adenomas treated by an endoscopic approach. Rates were 92.3% (microadenomas) and 57.1% (macroadenomas) for prolactin-secreting tumors, 75% (microadenomas) and 40% (macroadenomas) for GH-secreting tumors and 54.5% (microadenomas) and 71.4% (macroadenomas) for adrenocorticotropic hormonesecreting tumors.…”
Section: Pituitary Adenomasmentioning
confidence: 99%